Gregory Gene Freitag - 17 Jun 2021 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/Gregory Freitag
Issuer symbol
AXGN
Transactions as of
17 Jun 2021
Net transactions value
-$6,376
Form type
4
Filing time
21 Jun 2021, 16:17:56 UTC
Previous filing
17 Jun 2021
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $177,322 +9,250 +2.6% $19.17 364,556 17 Jun 2021 Direct F1
transaction AXGN Common Stock Tax liability $183,699 -8,781 -2.4% $20.92 355,775 17 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Employee Stock Option (right to purchase) Options Exercise $0 -9,250 -100% $0.000000* 0 17 Jun 2021 Common Stock 9,250 $19.17 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Of the 8,781 reported shares, 8,477 shares were swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule 16b-3. Additionally, 304 shares of common stock were surrendered to satisfy the reporting person's tax withholding liability. In total, the reporting person received 469 additional shares of common stock.
F2 All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on December 27, 2022 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.